MedPath

EXJADE 250MG DISPERSIBLE TABLETS

Trade Name: EXJADE 250MG DISPERSIBLE TABLETS

Generic Name: DEFERASIROX

Valid
Registration Number

0901244697

Registration Year

2006

Drug Type

NCE

Legal Status

Prescription

Detailed Information

Comprehensive information about this SFDA approval including dosage forms, packaging, and storage conditions.

Dosage and Strength Information

Dispersible tablet

250mg

Oral use

Blister

Storage and Shelf Life

store below 25°c

36 Months

ATC Classification

V03AC03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.